Skip to Main Content

Paper Details

Olaparib in Patients With Metastatic Prostate Cancer With <i>BRCA1</i>/<i>2</i> Mutation: Results From the TAPUR Study.
JCO Precis Oncol
2
2023
Metastatic Prostate Cancer, Olaparib, Patients, TAPUR, WBC, advanced cancers, anemia, aspiration, fatigue, genomic variants, mCRPC, metastatic castrate-resistant prostate cancer, olaparib, patients, prostate cancer
Author NameAffiliation
Eddy S YangO'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham School of Medicine
Eddy S YangO'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham School of Medicine
Elizabeth Garrett-MayerAmerican Society of Clinical Oncology
  • 1 - 3

Datasets

Release 1.2